Skip to content
Review Open access

Organoids in Precision Radiotherapy: Methodological Foundations, Tumor‐Specific Evidence, and Translational Roadmaps

Sep 2026 · Cancer Medicine · Vol 15 · 0 citations · 94 references
Medicine

Abstract

Radiotherapy remains a cornerstone of cancer treatment, while its efficacy is often limited by tumor radioresistance and the risk of normal tissue toxicity. Conventional preclinical models, including two‐dimensional (2D) cell cultures and murine xenografts, exhibit significant limitations in recapitulating human tumor pathophysiology, thereby impeding the clinical translation of novel radiotherapeutic strategies. Patient‐derived organoids (PDOs) have emerged as transformative three‐dimensional (3D) ex vivo models that recapitulate key aspects of original tumor heterogeneity and are increasingly applied in oncology research.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.